日本藥物輸送裝置市場報告（按給藥途徑、應用、最終用戶和地區分類，2026-2034年）

Japan Drug Delivery Devices Market Report by Route of Administration, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本藥物輸送裝置市場規模達132億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到187億美元，2026年至2034年間的複合年成長率（CAGR）為3.96%。推動該市場成長的因素包括慢性病盛行率的上升、藥物研發的進步以及新型藥物傳輸技術的持續開發。

本報告解答的關鍵問題：

日本藥物傳輸設備市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本藥物輸送設備市場產生了哪些影響？
日本藥物輸送裝置市場依給藥途徑分類的組成是怎樣的？
日本藥物輸送設備市場按應用領域分類的組成是怎樣的？
日本藥物輸送設備市場依最終用戶分類的組成是怎樣的？
日本藥物輸送設備市場價值鏈的各個階段有哪些？
日本藥物輸送裝置的關鍵促進因素和挑戰是什麼？
日本藥物輸送設備市場的結構是怎麼樣的？主要參與者有哪些？
日本藥物輸送設備市場的競爭程度如何？

Japan drug delivery devices market size reached USD 13.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.7 Billion by 2034, exhibiting a growth rate (CAGR) of 3.96% during 2026-2034. The market for these devices is driven by the rising prevalence of chronic diseases, advancements in pharmaceutical research, and the continual development of novel drug delivery technologies

Drug delivery devices constitute a fundamental component of medical equipment designed to administer medications and therapeutic agents across diverse routes in the human body. They are specifically to ensure precise, controlled, and targeted delivery of drugs to achieve optimal therapeutic effect while minimizing side effects. They encompass a variety of forms including, but not limited to, injectors, inhalers, patches, and implantable devices. The evolution of drug delivery devices is crucial in addressing the growing need for innovative solutions to administer medication effectively to treat various diseases and conditions. They also play a pivotal role in transforming therapeutic practices, thereby contributing significantly to the advancement of healthcare solutions.

Japan Drug Delivery Devices Market Trends:

The Japan drug delivery devices market is traversing a phase of substantial growth and transformation, propelled by several pivotal drivers and marked by emerging trends. A primary driver is the escalating prevalence of chronic diseases and aging population in Japan, necessitating advanced therapeutic approaches and effective drug delivery systems. These health conditions demand enhanced medical attention and innovative therapeutic solutions, paving the way for the proliferation of sophisticated drug delivery devices in the country. Japan's strong focus on research and development is another significant catalyst, fostering innovations and advancements in drug delivery technologies. The emphasis on developing patient-centric devices that are more convenient, efficient, and less invasive is driving the trend of personalization and customization in the market. Technological advancements are leading to the emergence of novel drug delivery systems, aiming to optimize therapeutic outcomes and mitigate adverse effects. Moreover, a supportive regulatory environment and substantial investments in healthcare are facilitating the rapid adoption of new technologies and ensuring the safety and efficacy of these devices. The increasing consumer awareness and healthcare literacy are also contributing to the growing demand for advanced drug delivery devices. The convergence of nanotechnology with drug delivery represents a noteworthy trend, offering opportunities for creating devices with enhanced precision and control. In essence, the amalgamation of innovative technologies, burgeoning healthcare needs, and a conducive regulatory landscape is shaping the trajectory of the drug delivery devices market in Japan, highlighting a promising outlook filled with innovations and opportunities.

Japan Drug Delivery Devices Market Segmentation:

Route of Administration Insights:

Injectable
Topical
Ocular
Others

Application Insights:

Cancer
Cardiovascular
Diabetes
Infectious diseases
Others

End User Insights:

Hospitals
Ambulatory Surgical Centers
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan drug delivery devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan drug delivery devices market?
What is the breakup of the Japan drug delivery devices market on the basis of route of administration?
What is the breakup of the Japan drug delivery devices market on the basis of application?
What is the breakup of the Japan drug delivery devices market on the basis of end user?
What are the various stages in the value chain of the Japan drug delivery devices market?
What are the key driving factors and challenges in the Japan drug delivery devices?
What is the structure of the Japan drug delivery devices market and who are the key players?
What is the degree of competition in the Japan drug delivery devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Delivery Devices Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Drug Delivery Devices Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Drug Delivery Devices Market - Breakup by Route of Administration

6.1 Injectable
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Topical
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Ocular
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Others
- 6.4.1 Historical and Current Market Trends (2020-2025)
- 6.4.2 Market Forecast (2026-2034)

7 Japan Drug Delivery Devices Market - Breakup by Application

7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Cardiovascular
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Infectious Diseases
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Drug Delivery Devices Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Ambulatory Surgical Centers
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2020-2025)
- 8.3.2 Market Forecast (2026-2034)

9 Japan Drug Delivery Devices Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Route of Administration
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Route of Administration
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Route of Administration
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Route of Administration
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Route of Administration
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Route of Administration
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Route of Administration
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Route of Administration
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Drug Delivery Devices Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Drug Delivery Devices Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis